This site is for US Audiences OnlyFor Non US Residents

SUPPORT SIGNUPFor Healthcare Professionals

Bayer Logo Bayer Logo Bayer Logo Bayer Logo

Taking Adempas
with some other
PAH medications

ADEMPAS CAN BE TAKEN ALONE OR USED IN COMBINATION WITH ERAs OR PCAs FOR THE TREATMENT OF PAH (WHO GROUP 1)

Adempas can be taken alone or used in combination with medications called endothelin receptor antagonists (ERAs) or prostacyclin analogs (PCAs) (in inhaled, oral, or subcutaneous injection formulations) to treat pulmonary arterial hypertension (PAH) (WHO Group 1).

In a clinical trial, Adempas was studied in patients taking it by itself and also in combination with an ERA or PCA. Studies showed that Adempas may help your symptoms, even if you are being treated for PAH with an ERA or PCA. If you are taking these medications, your doctor may prescribe Adempas in addition to your current treatment to help your symptoms. If you are already taking an ERA or PCA and you would like to learn more about adding Adempas, talk to your doctor.

Do not take Adempas if you take certain other medicines that contain sildenafil (Revatio or Viagra), tadalafil (Adcirca or Cialis), vardenafil (Levitra or Staxyn), dipyridamole, or theophylline. Revatio and Adcirca are also used to treat PAH.

Do not take Adempas:

  • Within 24 hours of sildenafil
  • 24 hours before or within 48 hours after tadalafil

Talk to your doctor about other medications that can be taken with Adempas.

TREATMENTS FOR PAH TARGET DIFFERENT PATHWAYS

Adempas targets a different pathway than ERAs and PCAs to treat symptoms of PAH.

Adempas works with a chemical already in your body called sGC (soluble guanylate cyclase) to help keep blood vessels open and help more blood flow through your lung blood vessels. This happens within the NO-sGC-cGMP* pathway.

ERAs target a different pathway called the endothelin pathway. PCAs target a pathway called the prostacyclin pathway.

Your doctor may prescribe you treatments in one or more of these pathways.

No-sGC-cGMP PATHWAY
Drugs that work in this pathway either relax or prevent narrowing of the blood vessels in the lungs
ENODOTHELIN PATHWAY
Drugs that work in this pathway help to prevent narrowing of blood vessels in the lungs
PROSTACYCLIN PATHWAY
Drugs that work in this pathway relax blood vessels in the lungs

 

Learn More About How Adempas Works

ADEMPAS MAY HELP YOU WALK FARTHER EVEN IF YOU ARE TAKING AN ERA OR PCA FOR PAH

In a clinical study, patients with PAH who received Adempas and an ERA or PCA were able to walk farther (as measured by 6-minute walk distance) than patients who received placebo (an ERA or PCA without Adempas).

PATENT-1 was a 12-week clinical study that included 443 patients with PAH. About half of the patients had never been treated for PAH (50%; n=189/443), 44% (n=167/443) had been previously treated with an ERA, and 6% (n=27/443) had been previously treated with a PCA (inhaled, oral, or subcutaneous).

Patients walked 74 feet farther with Adempas and ERA therapy than with placebo

 

Patients walked 314 feet farther with Adempas and PCA therapy than with placebo

 

Doctor Discuss

 

TALK TO YOUR DOCTOR ABOUT ADDING ADEMPAS

If you are already taking an ERA or PCA and you would like to learn more about adding Adempas, talk to your doctor. For helpful tips on getting the most out of your conversations with your doctor and setting treatment goals, download the useful guide below and take it with you to your next visit.

Get tips for talking to your doctor

Want to learn more about taking care of yourself?View the Taking Care of Yourself section here
 

Want to learn more about taking care of yourself?

View the Taking Care of Yourself section here

 
MORE IMPORTANT SAFETY INFORMATION
Important Safety Information and Indications

Adempas can cause serious birth defects if taken during pregnancy.

  • Females must not be pregnant when they start taking Adempas (riociguat) tablets or become pregnant during treatment with Adempas.
  • Females who are able to get pregnant must have a negative pregnancy test before beginning treatment with Adempas, each month during treatment, and 1 month after you stop treatment with Adempas. Talk to your doctor about your menstrual cycle. Your doctor will decide when to do the test.
    • Females who are able to get pregnant are females who:
      • Have entered puberty, even if they have not started their period, have a uterus, and have not gone through menopause (have not had a period for at least 12 months for natural reasons, or have had their ovaries removed).
    • Females who are not able to get pregnant are females who:
      • Have not yet entered puberty, do not have a uterus, or have gone through menopause.

Females who are able to get pregnant must use two acceptable forms of birth control, during Adempas treatment and for one month after stopping Adempas.

  • If you have had a tubal sterilization, have a progesterone implant, or have an IUD (intrauterine device), these methods can be used alone and no other form of birth control is needed.
  • Talk with your doctor or gynecologist (a doctor who specializes in female reproduction) to find out how to prevent pregnancy during treatment with Adempas.
    • Do not have unprotected sex. Talk to your doctor or pharmacist right away if you have unprotected sex or if you think your birth control has failed. Your doctor may tell you to use emergency birth control.
    • Tell your doctor right away if you miss a menstrual period or think you may be pregnant for any reason.

If you are the parent or caregiver of a female child who started taking Adempas before reaching puberty, you should check your child regularly to see if she is developing signs of puberty. Tell your doctor right away if you notice that she is developing breast buds or any pubic hair. Your doctor should decide if your child has reached puberty. Your child may reach puberty before having her first menstrual period.

Females can only receive Adempas through a restricted program called the Adempas Risk Evaluation and Mitigation Strategies (REMS) program. If you are a female who can become pregnant, you must talk to your doctor, understand the benefits and risks of Adempas, and agree to all of the instructions in the Adempas REMS program. Males can receive Adempas without taking part in the Adempas REMS program.

Do not take Adempas if:

  • you are pregnant, plan to become pregnant, or become pregnant during treatment with Adempas. Adempas can cause serious birth defects.
  • you take:
    • another medicine called a soluble guanylate cyclase stimulator (sGC). Ask your healthcare provider if you are not sure if you are taking an sGC medicine
    • a nitrate medicine to treat high blood pressure or heart disease, such as nitroglycerin, or a medicine called a nitric oxide donor, such as amyl nitrite
    • certain other medicines that contain sildenafil (Revatio or Viagra), tadalafil (Adcirca or Cialis), vardenafil (Levitra or Staxyn), dipyridamole, or theophylline. Revatio and Adcirca are also used to treat PAH
  • you have pulmonary hypertension associated with idiopathic interstitial pneumonias (PH-IIP).

Ask your doctor or pharmacist if you are not sure if you take any of the medicines listed above.

Before you take Adempas, tell your doctor if you:

  • smoke; have recently had serious bleeding from your lungs, or if you have had a medical procedure called bronchial arterial embolization to stop you from coughing up blood; have problems with your heart or blood circulation; have low blood pressure; have liver problems; have kidney problems or are on dialysis; have narrowing of the pulmonary veins, a condition called pulmonary veno-occlusive disease or PVOD; have any other medical conditions.

Tell your doctor about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements.
Adempas and other medicines may affect each other causing side effects. Do not start any new medicine until you check with your doctor.

What should I avoid while taking Adempas?

  • Do not get pregnant while taking Adempas. If you miss a menstrual period, or think you might be pregnant, call your doctor right away.
  • It is not known if Adempas passes into your breast milk. You should not breastfeed if you take Adempas. Talk to your doctor about the best way to feed your baby if you take Adempas.
  • Adempas may make you feel dizzy. Do not drive, operate machinery, or do other activities that require mental alertness or coordination until you know how Adempas affects you. Talk with your doctor if you are concerned about when it is safe for you to do these activities.
  • Smoking. Adempas may not work as well if you smoke during treatment. Tell your doctor if you stop smoking or start smoking during treatment with Adempas, because your dose of Adempas may need to be changed.

Adempas can cause serious side effects including:

  • Serious birth defects.
  • Reduced blood pressure. This may cause symptoms of low blood pressure, such as lightheadedness, chest pain, and dizziness especially in people who are dehydrated, have a severe blockage of blood flow out of the heart, or have certain other medical problems. Your doctor will check you for any of these problems.
  • Increased risk of bleeding, including bleeding from the respiratory tract. Tell your doctor right away if you cough up blood during treatment with Adempas.
  • Worsening of symptoms in people with Pulmonary Veno-Occlusive Disease (PVOD). If you have PVOD, treatment with Adempas may cause a build-up of fluid in your lungs (pulmonary edema) which may result in shortness of breath. Your doctor may tell you to stop taking Adempas and switch you to a different medicine.

The most common side effects of Adempas are:

  • Headache; dizziness; indigestion; swelling of your hands, legs, feet, and ankles (peripheral edema); nausea; diarrhea; and vomiting

Tell your doctor if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of Adempas.

Indications

Adempas is a prescription medicine used to treat adults with:

  • chronic thromboembolic pulmonary hypertension (CTEPH) (WHO Group 4) treated with surgery but who continue to have high pulmonary blood pressure (persistent) or it comes back after surgery (recurrent), or that cannot be treated with surgery.
    • CTEPH is a type of high blood pressure in the arteries of your lungs caused by blood clots that narrow or block blood flow. Adempas can improve your ability to exercise (measured by 6-minute walk distance) and can help to improve some of your symptoms.
  • pulmonary arterial hypertension (PAH) (WHO Group 1)
    • PAH is a type of high blood pressure in the arteries of your lungs. Adempas can improve your ability to exercise (measured by 6-minute walk distance), improve some of your symptoms, and help slow down the worsening of your physical condition [this includes death, heart/lung transplant, a surgery to reduce pressure in your lung, hospitalization for worsening of pulmonary hypertension, start of a new PAH-specific treatment, continued decline in your ability to exercise (measured by a 6-minute walk distance) and some of your symptoms].

The Adempas clinical studies included mostly patients with WHO functional class II-III symptoms. It is unknown if Adempas is safe and effective in children.

For important risk and use information please see the full Prescribing Information , including Boxed Warning and Medication Guide .

©2020 Bayer

You are encouraged to report side effects or quality complaints of products to the FDA by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088. For Bayer products, you can report these directly to Bayer by clicking here.

BAYER, the Bayer Cross, Adempas, and Aim are registered trademarks of Bayer.

All other trademarks are property of their respective owners. These trademark owners are not affiliated with Bayer and do not sponsor or endorse Bayer or this product.

© 2021 Bayer. All rights reserved.

Site Last Modified: 10/2021

Bayer